1.The effect of folic acid on DNA methylation of tumor-related genes in healthy human peripheral blood mononuclear cells
Ting YE ; Linna FU ; Wenying LI ; Yingxuan CHEN ; Jingyuan FANG
Chinese Journal of Digestion 2011;31(5):312-317
Objective To investigate the effect of folic acid on the DNA methylation of tumorrelated genes promoters in healthy human peripheral blood mononuclear cells(PBMC). Methods Ten healthy volunteers were divided into two groups, and were randomized to receive either 5 mg folic acid (n=5)or placebo(n = 5) , one time per day for 3 months. The serum folic acid concentration was detected with chemiluminescence enzyme immunoassay kit before and after the intervention. The methylation statuses of five tumor-related genes promoter, including oncogenes c-myc, c-Ha-ras,tumor suppressor genes p16INK4A, E-cadherin and mismatch repair gene hMLH1 in PBMC were detected by bisufite sequencing. Results After folic acid intervention, the level of serum folic acid increased significantly in intervention group (t= -4. 739,P<0. 05) , however no significant difference in control group. After three-month folic acid intervention, the level of methylation of oncogene c-myc promoter increased from 4%, 3. 3%, 4. 1% before intervention, one week after intervention, one month after intervention respectively to 8%(t= -4. 079,P<0. 05), while no significant change in placebo taken group. Before and after the folic acid intervention, there was no significant difference of DNA methylation of other tumor-related genes promoter, including c-Ha-ras、E-cadherin、p16INK4Aand hMLH1. Conclusion Folic acid intervention can up-regulate DNA methylation of oncogene c-myc promoter, but can not affect the promoter methylation status of tumor suppressor genes E-cadherin,p16INK4Aand hMLH1.
2.Biological characteristics of Ebola virus:research advances
Yi ZHANG ; Yinglong QU ; Zhendong GUO ; Siyan ZHAO ; Yingying FU ; Hongyan ZHAO ; Zhongyi WANG ; Zongzheng ZHAO ; Linna LIU ; Jun QIAN
Military Medical Sciences 2015;(5):386-389
Ebola virus disease , which can cause ebola hemorrhagic fever , is a potent zoonotic infectious virus disease . In 2014 , Ebola virus spread across West Africa and it has become a new major threat to global public health .This article summarizes the structural features of Ebola virus , transmission characteristics , interactions ,animal models .
3.Advances in biological spectroscopy detection of pathogenic microorganisms
Zhendong GUO ; Siyan ZHAO ; Yi ZHANG ; Yingying FU ; Hongyan ZHAO ; Yinglong QU ; Zhongyi WANG ; Zongzheng ZHAO ; Jun QIAN ; Linna LIU
Military Medical Sciences 2015;(4):311-315
Detection of pathogenic microorganisms has been a hot research field of microbiology.Conventional detection methods,such as isolation and culture, PCR technology, ELISA and genomic sequencing,are all time-consuming and com-plex.Because of the advantages of quick-testing, accuracy, safety and efficiency, spectroscopy has become a new non-inva-sive testing technology and has witnessed rapid development in pathogen detection and disease diagnosis.This article intro-duces three types of common spectroscopy technologies ( laser excitation fluorescence spectroscopy, infrared spectroscopy and Raman spectroscopy) , and also explains how they work in the detection of pathogenic microorganisms.
4.Research development of human infection with H5N6 avian influenza virus
Lina LIU ; Zongzheng ZHAO ; Zhendong GUO ; Yi ZHANG ; Yingying FU ; Zhongyi WANG ; Hongqi SUN ; Jiaming LI ; Tianrui ZHANG ; Chunmao ZHANG ; Linna LIU ; Jun QIAN
Military Medical Sciences 2017;41(1):69-72
Avian influenza virus is a new recombinant virus , which can cause severe respiratory symptoms ,such as short course,acute disease,and a high mortality rate.The purpose of this paper was to summarize the current status of this virus in terms of its epidemiology ,genetic evolution and virulence .By introducing the advancement in the research of this subtype virus, we hope to provide data and evidence ,for effective surveillance and prevention of this virus .
5.Exploration of the relationship between sleep quality and negative life events and coping styles in adolescents based on structural equation model
Wenfen ZHU ; Linna KONG ; Yixiao FU ; Zhiyin DU
Sichuan Mental Health 2022;35(6):566-571
ObjectiveTo explore the correlation of sleep quality with negative life events and coping styles in adolescents based on structural equation modeling, and to provide references for improving the adolescents' sleep quality. MethodsFrom December 2021 to May 2022, a total of 767 junior middle school students from three schools in Chongqing were enrolled, and assessed using Pittsburgh Sleep Quality Index (PSQI), Adolescent Self-rating Life Events Checklist (ASLEC) and Simplified Coping Style Questionnaire (SCSQ). Then the structural equation model was applied to discuss the correlation of sleep quality with negative life events and coping styles in adolescents. ResultsA total of 222 adolescents (28.94%) were found to have sleep disorders. PSQI score was positively correlated with ASLEC score and negative coping dimension score of SCSQ (r=0.612, 0.590, P<0.01), and negatively correlated with positive coping dimension score of SCSQ (r=-0.435, P<0.01). The structural equation model of the relationship between negative life events, coping styles and sleep quality denoted that negative life events exhibited both direct and indirect positive effects on sleep quality (β=0.448, 0.322, P<0.05), positive coping style had direct negative effects on sleep quality (β=-0.368, P<0.05), and negative coping style had direct positive effects on sleep quality (β=0.442, P<0.05). ConclusionNegative life events and negative coping style cause adverse effects on adolescents' sleep quality, while positive coping style exerts positive effects on adolescents' sleep quality.
6.Research progress of astrocyte phagocytosis in Alzheimer's disease
Xiaoli QIN ; Linna ZHAO ; Rong FU ; Yuying GUO ; Shixin XU
Basic & Clinical Medicine 2024;44(8):1180-1184
Astrocytes are heavily activated in Alzheimer's disease,engulfing damaged synapses,Aβ proteins,Tau proteins,apoptotic cells and other substrates.However,these substrates are difficult to degrade,accumulate as the disease progresses,and impair the phagocytosis of astrocytes.During phagocytosis,astrocytes recognize different substrates through a variety of phagocytosis receptors and partially degrade the substrates through degrad-ing enzymes and lysosomal pathways.The accumulation of Aβ and Tau proteins in astrocytes caused astrocyte im-mune and metabolic disorders,and Aβ toxicity changed after phagocytosis.In addition,astrocytes and microglia form a complementary pattern and cooperate to complete phagocytosis through interaction.Regulating the pathway of astrocyte phagocytosis and degradation is believed to be a potential novo therapeutic for clinical treatment of Alzheimer's disease.
7.Study of discrepancy in subjective and objective cognitive function in patients with depressive disorder
Linna FU ; Min WANG ; Xiao YANG ; Yikai DOU ; Jinxue WEI ; Zongling HE ; Yue YU ; Xiao CAI ; Xiaohong MA
Sichuan Mental Health 2024;37(1):26-32
BackgroundThere exist differences in the subjective and objective cognitive functions of patients with depressive disorder, ane there are limited research on influencing factors of such phenomenon currently. ObjectiveTo explore the differences in subjective and objective cognitive function in patients with depressive disorder as well as influencing factors, and to provide references for further understanding of cognitive impairment in patients with depressive disorder. MethodsA total of 77 patients with depressive disorder who received outpatient or inpatient treatment in the Fourth People's Hospital of Chengdu from January 13, 2022 to December 11, 2023 were selected for the study. These patients also met the diagnostic criteria of Diagnostic and Statistical Manual of Mental Disorders, fifth edition(DSM-5). Various tools were employed to assess patients in this study: Montgomery-Asberg Depression Rating Scale (MADRS) for the depressive symptoms, Perceived Deficits Questionnaire for Depression (PDQ-D) and Chinese Version of Brief Neurocognitive Test Battery (C-BCT) for the subjective and objective cognitive function, Sheehan Disability Scale (SDS) for the social function, and Clinical Global Impression-Severity of Illness(CGI-SI) for the severity of patient's condition. Pearson correlation analysis was used to examine the correlation of subjective and objective cognitive function and their differences with age, years of education, MADRS total score, SDS total score, and CGI-SI score. Multiple linear regression was used to explore the influencing factors of the differences between subjective and objective cognitive function. ResultsThere was a statistically significant difference in the total PDQ-D scores and the difference of subjective and objective cognitive function (D value) between depressive patients with and without medication (t=-4.228, -2.392, P<0.05 or 0.01). There was no statistically significant correlation in subjective and objective cognitive function in patients with depressive disorder (r=-0.148, P>0.05). Negative correlations can be observed between the PDQ-D total score and age or years of education (r=-0.333, -0.369, P<0.01). The PDQ-D total score was positively correlated with MADRS total score, SDS total score and CGI-SI score (r=0.487, 0.637, 0.434, P<0.01). D value was negatively correlated with age and years of education (r=-0.411, -0.362, P<0.01), while positively correlated with MADRS total score, SDS total score and CGI-SI score (r=0.259, 0.468, 0.299, P<0.05 or 0.01). Age (β=-0.328, P<0.01) and SDS total score (β=0.409, P<0.01) were two predictive factors for D value. ConclusionThe difference between subjective and objective cognitive function among patients with depressive disorder is related to several factors including age, years of education, severity of symptoms and impairment of social function. [Funded by Surface Project of National Natural Science Foundation of China (number, 62173069); Technological Innovation 2030-Major Project of "Brain Science and Brain-Like Research" (number, 2022ZD0211700); Key R&D Support Program and Major Application Demonstration Project of Chengdu Science and Technology Bureau (number, 2022-YF09-00023-SN)]